taiwan
23th -
24th
October 2024 | 
Taipei, Taiwan

Unveiling Taiwan's Biologics Excellence - From Innovation to Manufacturing

23th -
24th
October 2024 | 
Taipei, Taiwan
馃搯 Add to Google Calendar
0 +
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies

Taiwanese market focused event with agenda centered around bioprocessing excellence topics, clinical trials developments, case studies from CMOs, antibody & protein therapeutics, biologics packaging. Taiwan biopharma's are majorly start-ups or small-scale companies hence they are likely to attend to learn from the other companies on their manufacturing strategies and progress development.

Biologics World Taiwan 2024 is set to build upon its successful legacy since 2012, drawing over 300 pioneers globally. Focused on advancing the development and manufacturing of high-quality biologic drugs, vaccines, stem cells, and regenerative medicines in Taiwan for the global market, the upcoming conference will explore a diverse range of crucial topics. From current best R&D practices to the trajectory towards advanced manufacturing, Biologics World Taiwan 2024 promises to offer exclusive case studies and insights into the industry's key needs鈥攁ll in one comprehensive event that shouldn't be missed this year!

Biologics World Taiwan 2024

Explore the best practices of clinical development & trials with the ultimate goal of bringing new biologics products with proven therapeutic effect to the market. Learn how important the transition of preclinical research to clinical stages can mark a critical turning point of new biologics development.

Process optimization is the key success factor to develop biomanufacturing practices with high productivity and reduced cost. Immerse in the latest technology from Taiwan about the key practices to enhance productivity and speed in producing biologics.

The emerging CMO leaders from Taiwan are about to share their success stories with valuable insights and case studies to deliver the next generation manufacturing capabilities that Taiwan is providing to the world in making first class biologics products that can save millions of lives.

Antibody and Protein therapeutics are emerging as the most promising class of diagnostics to treat diseases in humans. Innovative sharing and case studies of effective antibody and protein treatments will be shared by the experts.

Innovative strategy of assay optimization, real time monitoring system with highest compromisation to quality control of biologics products to a direction of improving efficiency while advocating process automation are the keys to quicker market commercialization and regulatory compliance. Topics built around cost and process optimization with latest developments in analytics and quality to foster biologics enhancement.

Gain insights on the latest case studies of stem cell and regenerative medicine and recognize the potential of the cell and gene therapies.

Explore the latest CAR-T cell therapy advancements with impressive and effective solutions for antitumor treatments, especially against hematological malignancies from Taiwan’s key leaders in the CAR-T cell therapy industry.

Immerse in the best practices of cell & gene therapy products from the innovative showcase of the Taiwan market while considering the key factors and strategy that can lead to successful scale up and manufacturing of the products.

Listen to the key industry leaders of cell & gene therapy about their success stories of making the commercialization of the products a successful ones while replicating the strategies of effective manufacturing and commercialization in the market.

THANK YOU TO OUR SPONSORS









Biologics World Taiwan 2024

2023 Past Speakers

Abigail-Pittman

Abigail Pittman

Special Assistant to the CEO

PELL BIO-MED TECHNOLOGY
Taiwan
Albert-Yueh-Peng-Hung_photo_profile-2

Albert Yueh-Peng Hung,

Deputy Chief Operating Officer, Adimmune Corp, Taiwan

Alex-Blyth_photo_profile-2

Alex Blyth

CEO, LIft Biosciences, UK

UK
no-picture

Austin Tsai

Assistant Vice President,

Maria Von
Taiwan
Cheng-Han-Tsai_photo_profile-3

Cheng-Han Tsai

CEO, Cytena, Taiwan

Cheng-Yi-Jerry-Kuo_photo_profile

Cheng-Yi Jerry Kuo

Assist. Prof. PhD, Vice General Manager

UWELL BioPharma Co., Ltd
Taiwan
ChiaChu-Tsai_photo_profile-2

ChiaChu Tsai

Co-Founding Partner, COO, CellTech Innovation Studio Co., Taiwan

Dar-Jen-Hsieh_photo_profile

Dar-Jen Hsieh

CEO, ACRO Biomedical Co., Ltd.

Taiwan
Donggeon-Kim_photo_profile-2

Donggeon Kim

DVM, Ph.D. Principal Scientist Kanaph therapeutics, S Korea

Harry-Lam_photo_profile

Harry Lam

Chief Technical Officer & EVP of Technical Operations, Acepodia

Hem-Reddy_photo_profile-3

Hem Reddy

Director of APAC Business Development, Pfanstiehl Global Manufacturer, Taiwan

Jan-Mou-Lee_photo_profile

Jan Mou Lee

Founder & Scientific Advisor, Fullhope Biomedical Co., Ltd

Taiwan
Jason-Huang-M.D-J.D._photo_profile

Jason Huang M.D ; J.D.

CEO/CMO of ASCENDO Biotech

Taiwan
Julio-Lin_photo_profile

Julio Lin

Vice President, Blue Blood Biotech Corp

Karen-Wen-Ph.D._photo_profile

Karen Wen, Ph.D.

COO and Chief Strategy Officer, GenomeFrontier Therapeutics, Inc

Taiwan
Kevin-Chih-Yuan-Ho_photo_profile

Kevin Chih-Yuan Ho

Director of Clinical Department, Steminent Biotherapeutics Inc.

Taiwan
Li-Ming-Lu_photo_profile-3

Li-Ming Lu

Senior Clinical Project Manager, ARCE Therapeutics, Taiwan

Pearl-Fong_photo_profile-3

Pearl Fong

Development Manager, Eirgenix, Taiwan

Shugene-Lynn_photo_profile

Shugene Lynn

CEO and President, United BioPharma

Vatsala-Sadasivan_photo_profile

Vatsala Sadasivan

Global Operational Excellence Lead- R&D, Sanofi

no-picture

Verena Tan Wan Ying

Product Specialist, Chromatography

APAC Sartorius
Taiwan
Yan-Jye-Shyong_photo_profile

Yan-Jye Shyong

Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University

Taiwan
yen choo

Yen Choo

Associate Professor of Stem Cell Science and Regenerative Medicine

Lee Kong Chian School of Medicine, Nanyang Technological University
Singapore聽
Yun-Chi-Lu_photo_profile

Yun-Chi Lu

PhD., Chief Executive Officer, PrecisemAb Biotech, Taiwan

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

SOLUTION PROVIDERS
Limited Super SGD 4095/- (Ends by 28th July 2023)
  • Limited Special SGD 4395/- (Ends by 31st August 2023)
  • Early Bird SGD 4695/- (Ends by 29th September 2023)
  • Standard Rate SGD 4895
END-USERS
Limited Super SGD 2395/- (Ends by 28th July 2023)
  • Limited Special SGD 2595/- (Ends by 31st August 2023)
  • Early Bird SGD 2895/- (Ends by 29th September 2023)
  • Standard Rate SGD 3195

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Download Post Event Report Form

Download Attendee List

Download Prospectus Document Form

Download Brochure Document Form

Sponsorship Form

Download Agenda Form

Apply For Speaking Opportunity

Download Featured Content Form

Download List of Biopharma, CMO, CRO, CDMO and Big Pharma in China and Taiwan Brochure

Download Strategic Consulting Brochure

Download Case Study Consulting Digital Disruption

Download Case Study Consulting Revolutionizing Biopharmaceuticals

Download IMAPAC Custom Events Prospectus

Download Case Study : Fill-Finish Solution provider increasing its market share

Download Case Study : European CMO expanding into APAC

Download Case Study : China CDMO's New Gene Protein Facility Opening

Download Biologics Newsletter Sample

Download Cell and Gene Therapy Newsletter Sample

Download Vaccines Newsletter Sample

Download 1:1 Networking Meetings Case Study- High-end assembly solutions provider

Download 1:1 Networking Meetings Case Study- IT/Software Solution provider

Download 1:1 Networking Meetings Case Study- Biopharma Courier Service Provider

Download Ebook

Download Ebook

Download Events Calendar

Customised Webinar/Webcast

Download Customised Events Brochure

Contact us for Third Party Email Services